Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial.
暂无分享,去创建一个
B. Keam | K. Fizazi | G. Facchini | K. Chi | Z. Ye | A. Protheroe | A. Rodríguez-Antolín | P. De Porre | N. Matsubara | R. Damião | Tracy Li | M. Todd | Jason L. Martin | K. McQuarrie | H. Suttman | B. Jia | Jason L. Martin | J. Martin | Jason L. Martin